Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07521930 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Study acronym: INTENT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Start date pushed from Sep 2026 to Jan 2027 Eligibility criteria expanded, about 28 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 28 words
  2. Minor Start date: Aug 2026 to Sep 2026v3
  3. Notable Start date: Jun 2026 to Aug 2026v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,289 trials monitored
See 141 trials at risk
387 trials monitored
See 18 trials at risk
The goal of this clinical trial is to evaluate the safety and preliminary efficacy of an implantable device that records and stimulates different areas of the brain to allow adults affected by disabling paralysis (see Eligibility for more details) to control and receive feedback from assistive devices.
Trial Details
NCT Number NCT07521930
Lead Sponsor Johns Hopkins University
Collaborators: Blackrock Neurotech, JHU Applied Physics Laboratory, Kennedy Krieger Institute, Baltimore, MD
Conditions Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS), Muscular Disorders, Atrophic, Brain Stem Stroke, Spinal Cord Injuries (SCI), Muscular Dystrophies, Muscular Atrophy, Progressive, Pontine Hemorrhage +1 more
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov